Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Color Vision01:24

Color Vision

1.7K
Color perception begins in the retina, the light-sensitive layer at the back of the eye. Two main theories explain how colors are seen: the trichromatic theory and the opponent-process theory. The trichromatic theory, proposed by Thomas Young in 1802 and extended by Hermann von Helmholtz in 1852, suggests that color vision is based on three types of cone receptors in the retina. These cones are sensitive to different but overlapping ranges of wavelengths corresponding to red, blue, and green.
1.7K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

9.6K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
9.6K
Vision01:24

Vision

60.6K
Vision is the result of light being detected and transduced into neural signals by the retina of the eye. This information is then further analyzed and interpreted by the brain. First, light enters the front of the eye and is focused by the cornea and lens onto the retina—a thin sheet of neural tissue lining the back of the eye. Because of refraction through the convex lens of the eye, images are projected onto the retina upside-down and reversed.
60.6K
Anatomy of the Eyeball01:20

Anatomy of the Eyeball

10.1K
The eye is a spherical, hollow structure composed of three tissue layers. The outer layer — the fibrous tunic, comprises the sclera — a white structure — and the cornea, which is transparent. The sclera encompasses some of the ocular surface, most of which is not visible. However, the 'white of the eye' is distinctively visible in humans compared to other species. The cornea, a clear covering at the front of the eye, enables light penetration. The eye's middle...
10.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk of cardiovascular events and death following retinal arterial occlusion and transient monocular visual loss.

Scientific reports·2026
Same author

Serum Glial Fibrillary Acidic Protein and Retinal Neuronal Loss as Additive Prognostic Markers of Disability in Multiple Sclerosis.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.

The Lancet. Neurology·2026
Same author

Intermittent diplopia: a practical guide.

Practical neurology·2026
Same author

Correction: Treatment of post-vaccination optic neuritis: implications from the global SARS-CoV-2 vaccination effort.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
Same author

Corneal confocal microscopy as a paraclinical test in neurodegenerative disease: a scoping review.

The British journal of ophthalmology·2026
Same journal

Targeting neurodevelopmental miR132-3p promotes neuroprotection and axon regeneration after optic nerve injury in mice.

Brain research·2026
Same journal

Variability in acoustic startle response and prepulse inhibition across adulthood in Fragile X messenger ribonucleoprotein 1 knockout mice.

Brain research·2026
Same journal

Transcriptome-guided modeling reveals insulin-related metabolic dysfunction in SCA3 mouse cerebellum.

Brain research·2026
Same journal

Intranasal stromal cell-derived factor-1α mitigates parkinsonian deficits via dual modulation of neuroinflammation and gut microbiota in MPTP-induced models.

Brain research·2026
Same journal

Emotions, the amygdala, and the right hemisphere.

Brain research·2026
Same journal

Electroacupuncture treatment enhances hippocampal growth hormone level and restores mitochondrial function in vascular dementia rats.

Brain research·2026
See all related articles

Related Experiment Video

Updated: Feb 24, 2026

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.6K

Time is vision in recurrent optic neuritis.

Esther Osinga1, Bob van Oosten2, Willemien de Vries-Knoppert3

  • 1Department of Neurology, VUmc MS Centre Amsterdam, Netherlands; Expertise Centre Neuro-ophthalmology, VUmc, Amsterdam, Netherlands.

Brain Research
|August 22, 2017
PubMed
Summary
This summary is machine-generated.

Hyperacute corticosteroid treatment for recurrent optic neuritis (ON) significantly improves visual acuity and retinal nerve fiber layer thickness. Early intervention within two days offers better outcomes compared to delayed or no treatment, highlighting the importance of prompt corticosteroid therapy.

Keywords:
CorticosteroidsOptical coherence tomographyRecurrent optic neuritisVisual acuity

More Related Videos

Author Spotlight: Exploring the Link Between Time Perception of Visual Stimuli and Reading Skills
09:27

Author Spotlight: Exploring the Link Between Time Perception of Visual Stimuli and Reading Skills

Published on: January 19, 2024

1.8K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

2.0K

Related Experiment Videos

Last Updated: Feb 24, 2026

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.6K
Author Spotlight: Exploring the Link Between Time Perception of Visual Stimuli and Reading Skills
09:27

Author Spotlight: Exploring the Link Between Time Perception of Visual Stimuli and Reading Skills

Published on: January 19, 2024

1.8K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

2.0K

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Immunology

Background:

  • Optic neuritis (ON) involves inflammation preceding demyelination and axonal loss.
  • Corticosteroids' anti-inflammatory effects are potentially most potent during early ON phases.
  • Recruitment challenges in clinical trials for ON treatment exist.

Purpose of the Study:

  • To evaluate the impact of treatment initiation timing on visual outcomes in recurrent optic neuritis.
  • To assess the effect of early corticosteroid treatment on visual acuity and retinal structure in recurrent ON.

Main Methods:

  • Retrospective case note review of patients with recurrent optic neuritis.
  • Primary outcome: Change in best-corrected high-contrast visual acuity (BCVA).
  • Secondary outcomes: Changes in peripapillary retinal nerve fiber layer (pRNFL) and macular ganglion cell layer (mGCL) thickness via optical coherence tomography (OCT).

Main Results:

  • Treatment within <2 days resulted in better BCVA recovery (+0.02) and mGCL thickness preservation (-2.4µm) compared to delayed treatment (BCVA -0.2, mGCL -25.6µm) or no corticosteroids (BCVA -0.2, mGCL -5.0µm).
  • Delayed corticosteroid treatment and no treatment showed significantly worse visual and OCT outcomes (p=0.036 for BCVA, p=0.019 for mGCL).
  • Hyperacute corticosteroid treatment demonstrated a beneficial effect on visual and structural recovery in recurrent ON.

Conclusions:

  • Early initiation of corticosteroid treatment (<2 days) is associated with improved visual and retinal nerve fiber layer outcomes in recurrent optic neuritis.
  • These findings support the use of hyperacute corticosteroid therapy for recurrent ON.
  • Future prospective trials should consider recurrent ON patients for logistical advantages in recruitment.